SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 409 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $203 | -12.1% | 1,672 | -0.1% | 0.00% | 0.0% |
| Q1 2023 | $231 | +6.9% | 1,674 | +0.5% | 0.00% | 0.0% |
| Q4 2022 | $216 | -99.9% | 1,666 | -0.6% | 0.00% | -57.1% |
| Q4 2020 | $286,000 | +18.7% | 1,676 | -2.3% | 0.01% | +16.7% |
| Q3 2020 | $241,000 | -12.4% | 1,716 | 0.0% | 0.01% | -25.0% |
| Q2 2020 | $275,000 | +24.4% | 1,716 | 0.0% | 0.01% | +33.3% |
| Q4 2019 | $221,000 | -15.3% | 1,716 | 0.0% | 0.01% | -25.0% |
| Q2 2019 | $261,000 | +25.5% | 1,716 | -1.7% | 0.01% | -11.1% |
| Q1 2019 | $208,000 | -26.2% | 1,746 | 0.0% | 0.01% | -35.7% |
| Q3 2018 | $282,000 | +22.1% | 1,746 | 0.0% | 0.01% | +16.7% |
| Q2 2018 | $231,000 | – | 1,746 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
| Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
| Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
| Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
| Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
| STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
| Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
| RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
| Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |